← All news

FROM THE NEWS FEED

Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003

2026-08-05 • Psychedelic Invest

Article summary

CAMBRIDGE, Mass., August 05, 2026--Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address…

Continue to the original publication for the complete article.